|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-04
|
$430,565
|
$430,565
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma
|
1R01CA220581-01A1
|
$671,111
|
$335,556
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
$32,555
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Infection and Cancer Research: A New Frontier in Cancer Prevention and Control
|
5K05CA181320-05
|
$86,194
|
$17,239
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
|
5R01CA214588-02
|
$809,440
|
$809,440
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S1
|
$60,000
|
$2,400
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S2
|
$86,294
|
$3,452
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S3
|
$185,151
|
$7,406
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S4
|
$75,701
|
$3,028
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-20
|
$2,990,966
|
$119,639
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-03
|
$626,868
|
$206,866
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$105,897
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral
|
5UH3CA189901-05
|
$521,175
|
$521,175
|
HASAN, TAYYABA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Inhibition of Oral Tumorigenesis by Antitumor B
|
5R01CA205633-02
|
$504,001
|
$504,001
|
YOU, MING
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$388,700
|
N/A
|
National Institutes of Health
|
|
Defining the urban-rural continuum and distinguishing rural differences to prevent tobacco use
|
3R21CA205589-02S1
|
$146,947
|
$44,084
|
STILLMAN, FRANCES
|
NATIONAL OPINION RESEARCH CENTER
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$247,914
|
Alter, Blanche
|
DCEG (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$329
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Head and neck cancer
|
ZIA CP010213 10463
|
$1,001,660
|
$500,830
|
Chaturvedi, Anil
|
DCEG (NCI)
|
|
Oral HPV in Men Study
|
ZIA CP010209 10467
|
$28,137
|
$28,137
|
Kreimer, Aimee
|
DCEG (NCI)
|
|
Prospective Evaluation of HPV and Head and Neck Cancer
|
ZIA CP010209 10601
|
$46,802
|
$15,913
|
Kreimer, Aimee
|
DCEG (NCI)
|
|
Costa Rica HPV vaccine study
|
ZIA CP010217 01052
|
$695,376
|
$173,844
|
Kreimer, Aimee
|
DCEG (NCI)
|
|
Studies in the Janus Cohort
|
ZIA CP010120 02135
|
$47,817
|
$4,304
|
Rothman, Nat
|
DCEG (NCI)
|
|
The Role of WHSC1L1 in Squamous Cell Carcinoma of the Head and Neck
|
ZIA BC 011831
|
$452,420
|
$113,105
|
Saloura, Vassiliki
|
CCR (NCI)
|
|
Dyskeratosis Congenita
|
ZIA CP010190 10374
|
$91,300
|
$18,260
|
Savage, Sharon
|
DCEG (NCI)
|
|
Molecular mechanisms of membrane remodeling
|
ZIA BC 011682
|
$988,411
|
$197,682
|
Weigert, Roberto
|
CCR (NCI)
|
|
Peripherally-restricted cannabinoids for cancer and chemotherapy-induced pain
|
5R01CA196263-03
|
$492,705
|
$492,705
|
SCHMIDT, BRIAN
|
NEW YORK UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$64,202
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$2,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$2,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$2,462
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$584
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Feasibility of OncoMed to Improve Self-Management and Adherence to Oral Anticancer Medications
|
1R21CA226671-01A1
|
$206,190
|
$206,190
|
YANEZ, BETINA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA016058-42S1
|
$59,783
|
$1,793
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents
|
5R01CA211611-02
|
$356,114
|
$356,114
|
MALLERY, SUSAN
|
OHIO STATE UNIVERSITY
|
|
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries
|
5K01CA207599-02
|
$143,015
|
$143,015
|
OGHUMU, STEVE
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-42S2
|
$59,999
|
$1,800
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-42S3
|
$50,569
|
$1,517
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-42S4
|
$114,309
|
$3,429
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-42
|
$4,798,608
|
$143,958
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers
|
5U01CA188250-05
|
$587,041
|
$587,041
|
WEGHORST, CHRISTOPHER
|
OHIO STATE UNIVERSITY
|
|
Supportive Clinical Trial Tasks for Nanotechnology-Based Treatment of Oral Cancer
|
2R44CA192875-04
|
$999,072
|
$999,072
|
GOLDBERG, MANIJEH
|
PRIVO TECHNOLOGIES, LLC
|
|
Dual Mode Hand Held Intraoperative Imager
|
5R44CA168100-04
|
$662,164
|
$198,649
|
NAGARKAR, VIVEK
|
RADIATION MONITORING DEVICES, INC.
|
|
Use of Alternative Tobacco Products Among Homeless Youth
|
5R01CA204004-02
|
$291,072
|
$145,536
|
TUCKER, JOAN
|
RAND CORPORATION
|
|
Perceptions and Impact of Modified Risk Tobacco Product Communication Messages
|
1R37CA222002-01A1
|
$464,465
|
$139,340
|
WACKOWSKI, OLIVIA
|
RBHS-SCHOOL OF PUBLIC HEALTH
|
|
An Automated, Optical Imaging Platform for Early Detection of Oral Neoplasia
|
5F30CA213922-02
|
$49,524
|
$49,524
|
YANG, ERIC
|
RICE UNIVERSITY
|
|
Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer
|
1R43CA228815-01A1
|
$299,917
|
$299,917
|
BRAND, CHRISTIAN
|
SUMMIT BIOMEDICAL IMAGING, LLC
|
|
Endogenous fluorescence lifetime endoscopy for early detection of oral cancer and dysplasia
|
1R01CA218739-01A1
|
$486,517
|
$486,517
|
JO, JAVIER
|
TEXAS ENGINEERING EXPERIMENT STATION
|
|
Integration of endoscopic and CT data for radiation therapy treatment planning
|
5R01CA158925-06
|
$245,857
|
$122,929
|
ROSENMAN, JULIAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Low-cost Mobile Oral Cancer Screening for Low Resource Setting
|
4UH3CA239682-03
|
$922,631
|
$922,631
|
LIANG, RONGGUANG
|
UNIVERSITY OF ARIZONA
|
Total relevant funding to Buccal Cavity for this search: $13,977,656
|